Work

4025 POSTER A phase I/II study of sunitinib in combination with docetaxel (dcx) and prednisone (pdn) in patients with metastatic castrate-resistant prostate cancer (mCRPC)

Year: 2007

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(07)71093-5

Authors: A. Zurita, N.D. Shore, M.F. Kozloff, C.W. Ryan, T.M. Beer, E. Chow Maneval, I. Chen, C.J. Logothetis

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1994103214

Cites:

Cited by: 1

Related to: 10